These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17489574)

  • 1. Kv7 (KCNQ) channel modulators and neuropathic pain.
    Munro G; Dalby-Brown W
    J Med Chem; 2007 May; 50(11):2576-82. PubMed ID: 17489574
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and emerging targets to treat neuropathic pain.
    Butera JA
    J Med Chem; 2007 May; 50(11):2543-6. PubMed ID: 17489576
    [No Abstract]   [Full Text] [Related]  

  • 3. N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief.
    Childers WE; Baudy RB
    J Med Chem; 2007 May; 50(11):2557-62. PubMed ID: 17489572
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropathic pain: molecular complexity underlies continuing unmet medical need.
    Kennedy JD
    J Med Chem; 2007 May; 50(11):2547-56. PubMed ID: 17489577
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects for metabotropic glutamate 1 receptor antagonists in the treatment of neuropathic pain.
    Schkeryantz JM; Kingston AE; Johnson MP
    J Med Chem; 2007 May; 50(11):2563-8. PubMed ID: 17489573
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
    Baraldi PG; Preti D; Materazzi S; Geppetti P
    J Med Chem; 2010 Jul; 53(14):5085-107. PubMed ID: 20356305
    [No Abstract]   [Full Text] [Related]  

  • 7. Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain.
    Field MJ; Li Z; Schwarz JB
    J Med Chem; 2007 May; 50(11):2569-75. PubMed ID: 17489571
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium channel blockers.
    Kyle DJ; Ilyin VI
    J Med Chem; 2007 May; 50(11):2583-8. PubMed ID: 17489575
    [No Abstract]   [Full Text] [Related]  

  • 9. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
    Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
    Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNQ potassium channels in sensory system and neural circuits.
    Wang JJ; Li Y
    Acta Pharmacol Sin; 2016 Jan; 37(1):25-33. PubMed ID: 26687932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs?
    Silos-Santiago I
    Curr Opin Investig Drugs; 2008 Jan; 9(1):83-9. PubMed ID: 18183535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channels as therapeutic targets in neuropathic pain.
    Yaksh TL
    J Pain; 2006 Jan; 7(1 Suppl 1):S13-30. PubMed ID: 16426997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of transient receptor potential vanilloid type 1 channel modulators for the treatment of pain.
    Westaway SM
    J Med Chem; 2007 May; 50(11):2589-96. PubMed ID: 17489570
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds.
    Xiong Q; Gao Z; Wang W; Li M
    Trends Pharmacol Sci; 2008 Feb; 29(2):99-107. PubMed ID: 18206251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv7 channels as targets for the treatment of pain.
    Wickenden AD; McNaughton-Smith G
    Curr Pharm Des; 2009; 15(15):1773-98. PubMed ID: 19442190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of neuropathic pain.
    Ueda H; Rashid MH
    Drug News Perspect; 2003 Nov; 16(9):605-13. PubMed ID: 14702142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
    Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
    Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief.
    Colpaert FC
    Curr Opin Investig Drugs; 2006 Jan; 7(1):40-7. PubMed ID: 16425670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators.
    Osuma AT; Xu X; Wang Z; Van Camp JA; Freiberg GM
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126603. PubMed ID: 31416667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand modulation of KCNQ-encoded (K
    Naffaa MM; Al-Ewaidat OA
    Eur J Pharmacol; 2021 Sep; 906():174278. PubMed ID: 34174270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.